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TUDCA tauroursodeoxycholic acid 牛磺熊去氧胆酸
CTGF connective tissue growth factor 结缔组织生长因子
ER endoplasmic reticulum 内质网
UPR unfolded protein response 未折叠蛋白反应




eIF2α eukaryotic translation initiator
factor 2α
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的过表达以及 eIF2α磷酸化水平的增加均能导致 Yap表达的上调。我们在 Yap
的启动子序列上发现了 ATF4的结合位点，ATF4是在转录水平调控 YAP基因。
综上所述，我们发现了 Hippo信号通路主要效应分子 Yap新的调控机制，


















The Hippo signaling pathway was initially discovered in Drosophila
melanogaster, which is an evolutionary conserved signal transduction pathway. This
pathway controls organ size by regulating cell proliferation and apoptosis. Yap is the
important effector molecule of the Hippo signaling pathway. The loss of any
component upstream of this pathway results in the activation of Yap, increase in
proliferation, resistance to apoptosis, massive organ overgrowth and tumorigenesis.
The Hippo pathway phosphorylates Yap which promotes Yap cytoplasimic
localization and protein degradation. To explore the regulatory mechanism of Yap,
we found that the Endoplasmic Reticulum stress response could regulates the
expression of Yap.
ER stress response, also called unfolded protein response (UPR), results from
an excess of unfolded protein accumulated in endoplasmic reticulum. The UPR
could activate a series of signaling pathway, reduce the protein synthesis, and
improve the ability of protein folding and degradation rate, so as to build-up
homeostasis in endoplasmic reticulum. The chronic URP could induce cell death.
Previous studies showed that TUDCA could significantly decrease the mRNA level
of CTGF in rat hepatocyte. TUDCA is widely used to alleviate ER stress, and CTGF
is the major target gene of Yap. We speculate that the ER stress may play a
regulatory role in Yap expression. While three major UPR signals are activated
during ER stress, we found that only PERK-eIF2α-ATF4 pathway regulate Yap
expression. In We also found there is a ATF4 binding site in the promoter sequence
of Yap. Both the overexpression of ATF4 and increased phosphorylation level of
eIF2α lead to increaseed Yap expression.
Taken together, we have identified a new regulatory mechanism of Yap. We















stress reponse. Thus, UPR emerges as a potential therapeutic target in human
cancers driven by YAP.






















可以导致组织过度生长，Wts是哺乳动物中 Lats(Large tumor suppressor gene)的
同源蛋白。2002 年，Tapon 发现了 Hippo 信号通路的第二个成员，命名为
Salvador(Sav)，Sav含有WW结构域，是哺乳动物中WW45的同源蛋白[4]。2003





Sav、Hpo和Mats是 Hippo 信号通路的 4个核心激酶。随后在 2005年，Huang
等人利用酵母双杂交的筛选方法发现了一个能够和Wts/Lats相结合的蛋白，并
将其命名为 Yorki（Yki），Yki是 Hippo下游主要的效应因子[7]，能够通过结




















Lats1/2 、Mob1、Yap /TAZ[7]。哺乳动物 Hippo信号核心蛋白分子中，Mst1/ 2
为蛋白激酶，WW45和Mob1为构架蛋白，Yap/TAZ为转录共激活因子（图 1.3）。
在上游信号分子作用下，Mst1/2磷酸化而激活，并与WW45结合磷酸化 Lats1/2，





































白结合结构域（PBD）和一个 PPxY序列，Lats通过 PBD结合Mob1，通过 PPxYX
序列结合含有WW结构域的 Yap/TAZ，并使之磷酸化，促使其与 14-3-3蛋白
结合而滞留在细胞质中，从而抑制 Yap/TAZ的转录调控功能[16~18]。Lats的激酶
活性依赖于第 909位丝氨酸和第 1079位苏氨酸的磷酸化，Ser909是 Lats的自
磷酸化位点，Mob1的结合能够促进 Lats该位点的自磷酸化，Mst1/2磷酸化 Lats


















Degree papers are in the “Xiamen University Electronic Theses and 
Dissertations Database”.  
Fulltexts are available in the following ways: 
1. If your library is a CALIS member libraries, please log on 
http://etd.calis.edu.cn/ and submit requests online, or consult the interlibrary 
loan department in your library. 
2. For users of non-CALIS member libraries, please mail to etd@xmu.edu.cn 
for delivery details. 
厦
门
大
学
博
硕
士
论
文
摘
要
库
